Genomma Lab Internacional, S.A.B. de C.V.

Mexico Stock Exchange LABB.MX

Genomma Lab Internacional, S.A.B. de C.V. Revenue for the year ending December 31, 2023: USD 969.50 M

Genomma Lab Internacional, S.A.B. de C.V. Revenue is USD 969.50 M for the year ending December 31, 2023, a 12.42% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Genomma Lab Internacional, S.A.B. de C.V. Revenue for the year ending December 31, 2022 was USD 862.36 M, a 14.36% change year over year.
  • Genomma Lab Internacional, S.A.B. de C.V. Revenue for the year ending December 31, 2021 was USD 754.10 M, a 8.20% change year over year.
  • Genomma Lab Internacional, S.A.B. de C.V. Revenue for the year ending December 31, 2020 was USD 696.97 M, a 3.83% change year over year.
  • Genomma Lab Internacional, S.A.B. de C.V. Revenue for the year ending December 31, 2019 was USD 671.24 M, a 11.81% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
Mexico Stock Exchange: LABB.MX

Genomma Lab Internacional, S.A.B. de C.V.

CEO Mr. Juan Marco Sparvieri
IPO Date June 18, 2008
Location Mexico
Headquarters Av. Antonio Dovalí Jaime no.70
Employees 1,633
Sector Health Care
Industries
Description

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, and other brands. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Similar companies

GRUMAB.MX

Gruma, S.A.B. de C.V.

USD 15.62

-1.31%

GFNORTEO.MX

Grupo Financiero Banorte, S.A.B. de C.V.

USD 7.01

2.18%

ALFAA.MX

Alfa, S. A. B. de C. V.

USD 0.73

-2.52%

GMEXICOB.MX

Grupo México, S.A.B. de C.V.

USD 4.95

0.74%

KIMBERA.MX

Kimberly-Clark de México, S. A. B. de C. V.

USD 1.45

1.59%

StockViz Staff

January 15, 2025

Any question? Send us an email